Insulin Producing Cells
Insulin Producing Cells - Related Videos
08:29
Endothelial Cell Co-culture Mediates Maturation of Human Embryonic Stem Cell to Pancreatic Insulin Producing Cells in a Directed Differentiation Approach
0 Views •
Cited by 25 •
2012
The current study describes a directed differentiation approach in inducing pancreatic differentiation of human embryonic stem cells. Of great significance is the finding that endothelial cell co-culture mediates maturation of human embryonic stem cell derived pancreatic progenitors into insulin expressing cells.
08:41
Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
0 Views •
Cited by 2 •
2023
The differentiation of stem cells into islet cells provides an alternative solution to conventional diabetes treatment and disease modeling. We describe a detailed stem cell culture protocol that combines a commercial differentiation kit with a previously validated method to aid in producing insulin-secreting, stem cell-derived islets in a dish.
08:09
Isolation of Rat Adipose Tissue Mesenchymal Stem Cells for Differentiation into Insulin-producing Cells
0 Views •
Cited by 9 •
2022
Adipose tissue-derived mesenchymal stem cells (Ad-MSCs) can be a potential source of MSCs that differentiate into insulin-producing cells (IPCs). In this protocol, we provide detailed steps for the isolation and characterization of rat epididymal Ad-MSCs, followed by a simple, short protocol for the generation of IPCs from the same rat Ad-MSCs.
05:52
Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster
0 Views •
Cited by 16 •
2011
Conserved insulin signaling pathways found in the fruit fly Drosophila melanogaster make this organism a potential tool for modeling metabolic disorders including type II diabetes. To this end, it is critical to establish physiological assays to effectively measure systemic insulin action in peripheral glucose disposal in the adult fly.
08:45
Epigenetic Conversion as a Safe and Simple Method to Obtain Insulin-secreting Cells from Adult Skin Fibroblasts
0 Views •
Cited by 9 •
2016
Here, a new method that allows the conversion of adult skin fibroblasts into insulin-secreting cells is presented. This technique is based on epigenetic conversion, does not involve the use of retroviral vectors nor the acquisition of a stable pluripotent state. It is therefore highly promising for translational medicine applications.
FAQs
The response follows a linked metabolic and electrical sequence. Beta cells metabolize incoming glucose, increasing ATP production. Higher ATP closes ATP-sensitive potassium channels, changing the cell’s electrical state and triggering calcium entry. Calcium then stimulates insulin-containing secretory granules to release their contents. This coupling allows insulin output to track elevated glucose rather than occur independently of it.
Glucose responsiveness is a central design target because the intended function is regulated insulin production, not simply the presence of insulin-producing cells. Bioengineering strategies therefore aim to generate, maintain, or assemble cells that respond appropriately to elevated glucose. Achieving that behavior is relevant to diabetes research and to cell-based therapies seeking to restore metabolic control.
Stem cell differentiation provides a route for generating insulin-producing cells, whereas tissue engineering supports their assembly into designed cellular systems. These approaches address different bioengineering needs: one focuses on obtaining the relevant cell type, and the other on organizing cells for study or therapeutic development. Together, they support diabetes research, drug screening, and cell-based therapy design.
Biomaterials and encapsulation are used as bioengineering strategies to support insulin-producing cell systems beyond simple cell generation. In the source context, their principal objective is to improve graft survival and function, which are important requirements for cell-based therapies. These approaches therefore connect material design with the practical challenge of maintaining useful insulin-producing activity in therapeutic settings.
A source-supported workflow can begin with stem cell differentiation to generate the desired cells, followed by maintenance or assembly through tissue-engineering approaches. Biomaterials and encapsulation can then be incorporated as part of the engineered system, particularly when the goal includes improving graft survival and function. The resulting model can be directed toward mechanism studies, drug screening, or therapeutic development.
They provide experimental platforms for examining diabetes mechanisms and evaluating drug responses in systems centered on insulin production. Engineered cells can also support development of cell-based therapies intended to restore glucose-responsive insulin production. In that setting, researchers assess not only whether relevant cells can be generated or assembled, but also whether engineering strategies support graft survival and function.